Organon deploys TetraScience's Scientific Data Foundry to streamline quality testing workflows, enhance data integrity, and accelerate release of therapies for women. BOSTON, Dec. 16, 2025 /PRNewswire ...

Eli Lilly, the manufacturer of Mounjaro (tirzepatide), offers a savings card program for eligible participants. Other resources may also be available to help you save on the cost of your Mounjaro ...

Organon Sub-Saharan Africa deepened its leadership on women’s health and family planning at the WHX Leaders’ Summit in Accra, one of Africa’s biggest platforms for healthcare investment, innovation, ...

Shares of pharmaceutical company Organon (NYSE:OGN) fell 4.7% in the afternoon session after Barclays initiated coverage on the company with an 'Underweight' rating and a price target of $7.50. The ...

The Organon board of directors has approved the deal. The transaction is expected to close in the first quarter of 2026, subject to required regulatory approvals. “I am incredibly proud of the work ...

Organon (NYSE:OGN) reported better-than-expected earnings for the third quarter on Monday. The company posted third-quarter adjusted earnings of $1.01 per share on Monday, beating the consensus ...

Organon (NYSE:OGN) reported third-quarter adjusted earnings of $1.01 per share on Monday, beating the consensus estimate of 94 cents. The global healthcare company reported quarterly sales of $1.602 ...

JERSEY CITY, N.J. (AP) — JERSEY CITY, N.J. (AP) — Organon & Co. (OGN) on Monday reported third-quarter earnings of $160 million. The Jersey City, New Jersey-based company said it had profit of 61 ...

Women’s health company Organon is selling off its postpartum uterine bleeding or hemorrhage system to Laborie Medical Technologies in a deal worth up to $465 million. Organon first gained access to ...

Oct 27 (Reuters) - Organon (OGN.N), opens new tab said on Monday CEO Kevin Ali will resign from his role, after an internal investigation into sales of its Nexplanon contraceptive implant to ...